Millendo Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch MLND and buy or sell other stocks, options, and ETFs commission-free!

About MLND

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. 

CEO
Stephen R. Brady
CEOStephen R. Brady
Employees
17
Employees17
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
Founded
Employees
17
Employees17

MLND Key Statistics

Market cap
17.77M
Market cap17.77M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
4.71K
Average volume4.71K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$10.00
52 Week high$10.00
52 Week low
$1.45
52 Week low$1.45

MLND Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.